Moreover, IHC of matched biopsies from one patient before and after BRAFi resistance development showed a clear downregulation of ATM protein levels in the MAPKi resistant tumor compared with the treatment-naïve tumor (Fig. 3F). Here, ATM is linked to neoplasm.